Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome

Rheumatology (Oxford, England)

Volumn 55, Issue 7, 2016, Pages 1337-1339

  Barratt Due, Andreas ^a   Fløisand, Yngvar ^a   Orrem, Hilde L ^a   Kvam, Ann K ^a   Holme, Pål A ^a   Bergseth, Grethe ^a   Tjønnfjord, Geir E ^a   Mollnes, Tom E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; ECULIZUMAB; MONOCLONAL ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; COMPLEMENT ACTIVATION; FEMALE; HUMAN; IMMUNOLOGY; TERMINAL DISEASE;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATING AGENTS; FEMALE; HUMANS;

EID: 85016048774     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew040     Document Type: Article

References (0)